Pottstown Memorial Regional Cancer Center Exceeds National Standard of Care for Breast Care

Chemotherapy

Performance Rate:
Pottstown Memorial Regional Cancer Center - 100%
All CoC Approved Programs – 81.2%
View Performance Chart

As a standard of care, women under age 70 diagnosed with Breast Cancer whose hormone receptors are negative should include combination chemotherapy. This treatment is optimally given within 4 months of diagnosis.

This chemotherapy performance chart shows that Pottstown Memorial Regional Cancer Center Program has reached 100%, and when compared with other American College of Surgeons accredited cancer programs, exceeds state and national averages for this gold standard.

Radiation

Performance Rate:
Pottstown Memorial Regional Cancer Center – 96.7%
All CoC Approved Programs – 87%
View Performance Chart

As a standard of care, women who opt for Lumpectomy rather than Mastectomy for local surgical treatment for Breast Cancer should undergo a definitive course of Radiation therapy following surgery.

This radiation performace chart shows the combined modality of treatment was administered 96.7% of the time in the appropriate setting at PMRCC. This rate reflects 1 patient's refusal to comply with the radiation therapy following her lumpectomy.

Compared to other American College of Surgeons approved programs, Pottstown Memorial Regional Cancer Center exceeds state and national averages for this gold standard.

Hormone Therapies

Performance Rate:
Pottstown Memorial Regional Cancer Center – 100%
All CoC Approved Programs – 89.1%
View Performance Chart

As a standard of care, woman whose cancer cells are found to have Estrogen and Progesterone receptors on the cell surface will benefit from agents such as Tamoxifen and third generation aromatase inhibitors. These hormone therapies have increased local control and survival in patients diagnosed with Breast Cancer.

This hormone therapies performance chart shows that Pottstown Memorial Regional Cancer Center Program has reached 100%, and when compared with other American College of Surgeons accredited cancer programs, exceeds state and national averages for this gold standard.